Ben Hargreaves examines how AI cancer diagnosis is currently being implemented, and how it could evolve in the years ahead, including the potential for the exploration of digital biomarkers
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
